Ractigen Therapeutics
Ractigen is an early-stage pharmaceutical company.
Ractigen is an early-stage pharmaceutical company.
Ractigen Therapeutics has raised $31.0M across 1 round. Its most recent round was a Series Unknown of $31.0M in Jul 2026. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Ractigen Therapeutics is featured in
Similar companies
Kanurra is a pass-through pharmacy benefit manager for self-funded and level-funded companies.
Genta Kyushu Bio develops precision neuro circuit therapies for CNS and eye diseases via optogenetics and chemogenetics.
Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications.
Moonshot AI is an artificial intelligence company that develops large language models, multimodal AI systems, and developer APIs.
SenseTime is an AI healthcare firm that creates solutions for hospitals, research institutions, and the global medical market.
Super Panther is a Chinese technology business that focuses on the new energy commercial vehicle market.
Kai Medtech is a marketing and sales company for vascular intervention medical devices.
Xgene Pharmaceutical is a pharmaceutical company.
Beilian Zhuguan is a ToB Technology company focuses on promotion and development of digital economic infrastructure.
MORROR ART combines aural and visual art, incorporates display technology into speaker devices.
T-chef Tech is a robotic company that focuses on smart kitchen, 9D kitchen safety models, food safety application, and fast-food chains.
NewLine researches phage feed additives to prevent livestock infections.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.